Attached files

file filename
EX-10.63 - EX-10.63 - NOVELION THERAPEUTICS INC.d408043dex1063.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 31, 2012

 

 

QLT Inc.

(Exact Name of Registrant as specified in its charter)

 

 

 

British Columbia, Canada   000-17082   N/A

(State or Other Jurisdiction of

Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

887 Great Northern Way, Suite 101, Vancouver, B.C.

Canada, V5T 4T5

(Address of principal executive offices)

Registrant’s telephone number, including area code: (604) 707-7000

Not Applicable

(Registrant’s name or former address, if change since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 31, 2012, Linda Lupini, the Company’s Senior Vice President, Human Resources and Organizational Development, entered into an addendum to severance letter with the Company which, among other things, changed her termination date from August 31, 2012 to December 14, 2012. In connection with this change in termination date, Ms. Lupini will be entitled to receive additional severance amounts for the additional period she is working for the Company consistent with her Change of Control Agreement dated June 1, 2006.

A copy of the addendum is filed as Exhibit 10.63 hereto and is incorporated herein by reference. The description of the addendum included in this Item 5.02 is not complete and is qualified in its entirety by reference to the full text of the addendum set forth on Exhibit 10.63.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:

 

Number

  

Description

10.63    Addendum to Severance Letter between the Company and Linda Lupini, dated August 31, 2012


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

QLT INC.
By:   /s/ Sukhi Jagpal
Name:   Sukhi Jagpal
Title:   Interim Chief Financial Officer

Date: September 7, 2012